Meta-analysis of medical cannabis outcomes and associations with cancer
- PMID: 40303989
- PMCID: PMC12037605
- DOI: 10.3389/fonc.2025.1490621
Meta-analysis of medical cannabis outcomes and associations with cancer
Abstract
Background: Growing bodies of evidence suggest that cannabis may play a significant role in both oncological palliative care and as a direct anticarcinogenic agent, but classification as a Schedule I substance has complicated research into its therapeutic potential, leaving the state of research scattered and heterogeneous. This meta-analysis was conducted to determine the scientific consensus on medical cannabis' viability in cancer treatment.
Objective: The aim of this meta-analysis was to systematically assess the existing literature on medical cannabis, focusing on its therapeutic potential, safety profiles, and role in cancer treatment.
Methods: This study synthesized data from over 10,000 peer-reviewed research papers, encompassing 39,767 data points related to cannabis and various health outcomes. Using sentiment analysis, the study identified correlations between cannabis use and supported, not supported, and unclear sentiments across multiple categories, including cancer dynamics, health metrics, and cancer treatments. A sensitivity analysis was conducted to validate the reliability of the findings.
Results: The meta-analysis revealed a significant consensus supporting the use of medical cannabis in the categories of health metrics, cancer treatments, and cancer dynamics. The aggregated correlation strength of cannabis across all cancer topics indicates that support for medical cannabis is 31.38× stronger than opposition to it. The analysis highlighted the anti-inflammatory potential of cannabis, its use in managing cancer-related symptoms such as pain, nausea, and appetite loss, and explored the consensus on its use as an anticarcinogenic agent.
Discussion: The findings indicate a strong and growing consensus within the scientific community regarding the therapeutic benefits of cannabis, particularly in the context of cancer. The consistent correlation strengths for cannabis as both a palliative adjunct and a potential anticarcinogenic agent redefine the consensus around cannabis as a medical intervention.
Conclusion: The consistency of positive sentiments across a wide range of studies suggests that cannabis should be re-evaluated within the medical community as a treatment option. The findings have implications for public health research, clinical practice, and discussions surrounding the legal status of medical cannabis. These results suggest a need for further research to explore the full therapeutic potential of cannabis and address knowledge gaps.
Keywords: cancer; cannabis; data analytics; medical Marijuana; meta-analysis; oncology; outcomes; whole health.
Copyright © 2025 Castle, Marzolf, Morris and Bushell.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures














Similar articles
-
A systematic review of medical students' and professionals' attitudes and knowledge regarding medical cannabis.J Cannabis Res. 2021 Oct 12;3(1):47. doi: 10.1186/s42238-021-00100-1. J Cannabis Res. 2021. PMID: 34641976 Free PMC article. Review.
-
Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.Ont Health Technol Assess Ser. 2005;5(10):1-66. Epub 2005 Jun 1. Ont Health Technol Assess Ser. 2005. PMID: 23074461 Free PMC article.
-
Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.Campbell Syst Rev. 2018 Oct 4;14(1):1-86. doi: 10.4073/csr.2018.9. eCollection 2018. Campbell Syst Rev. 2018. PMID: 37131375 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
[Cannabis and cannabinoids in palliative care].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jul;62(7):830-835. doi: 10.1007/s00103-019-02967-1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019. PMID: 31161228 Review. German.
References
-
- Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana. Mathre ML. (Ed.), United Kingdom: McFarland, Incorporated, Publishers; (1997).
-
- Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc. (1964) 86(8):1646–7. doi: 10.1021/j01062046 - DOI
Publication types
LinkOut - more resources
Full Text Sources